Nyxoah (NYXH) Income from Non-Controlling Interests (2021 - 2024)
Nyxoah (NYXH) posted quarterly Income from Non-Controlling Interests of $594.1 million for Q4 2024, up 1515.91% year-over-year from $36.8 million in Q1 2024, and up 1515.91% quarter-over-quarter from -$42.0 million in Q4 2023.
Nyxoah (NYXH) Income from Non-Controlling Interests (2021 - 2024) Analysis & Trends
Nyxoah's Income from Non-Controlling Interests history runs 4 years deep, the most recent figure standing at $594.1 million for Q4 2024.
- In Q4 2024, Income from Non-Controlling Interests rose 1515.91% year-over-year to $594.1 million; the TTM figure through Dec 2024 stood at $637.2 million (changed N/A YoY), while the FY2024 annual figure was $830.3 million, up 2078.71% from the prior year.
- Income from Non-Controlling Interests for Q4 2024 stood at $594.1 million, up from -$42.0 million in the prior quarter.
- The five-year high for Income from Non-Controlling Interests was $594.1 million in Q4 2024, with the low at -$42.0 million in Q4 2023.
- The 4-year median for Income from Non-Controlling Interests is $42.5 million (2022), against an average of $159.3 million.
- The sharpest annual moves came in 2023 and 2024: Income from Non-Controlling Interests plunged 242.74% in 2023, then soared 1515.91% in 2024.
- Nyxoah's Income from Non-Controlling Interests stood at $97.2 million in 2021, then slumped by 112.59% to -$12.2 million in 2022, then slumped by 242.74% to -$42.0 million in 2023, then jumped by 1515.91% to $594.1 million in 2024.
- Business Quant data shows NYXH's Income from Non-Controlling Interests at $594.1 million in Q4 2024, -$42.0 million in Q4 2023, and -$12.2 million in Q4 2022.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | 6.60 Mn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | - |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | - |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | - |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | 79.00 Mn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | - |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | - |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | - |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | - |
| 10 | Nyxoah | 90.94 Mn | 90.94 Mn | 5.33 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 594.14 Mn |
| Dec 31, 2023 | -41.96 Mn |
| Dec 31, 2022 | -12.24 Mn |
| Dec 31, 2021 | 97.24 Mn |